Diagnosed too lateDecember 6, 2022Patient & Survivor CareRenal Cell CarcinomaPreventive CarePractice ManagementMixed TopicsMetastatic Breast CancerMelanoma
Doctor urges compassionate access to specialized radiotherapy for inoperable RCCDecember 2, 2022Renal Cell Carcinoma
Discontinuing immunotherapy: Is the infusion bag half empty or half full?November 23, 2022Lung CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersImmuno-oncology
How AI is, or will soon be, relevant in radiation oncologyNovember 13, 2022Lung CancerBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
Chronic stress, especially race related, may hasten cancer deathNovember 13, 2022Diversity in MedicineGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Third COVID booster benefits cancer patientsNovember 12, 2022COVID-19 UpdatesBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersLung Cancer
Atezolizumab fails to improve outcomes in postsurgery kidney cancerNovember 11, 2022Renal Cell Carcinoma
Is early-onset cancer an emerging global epidemic?October 5, 2022Preventive CareBreast CancerHead & Neck/Thyroid CancersGastrointestinal CancerGenitourinary CancerRenal Cell Carcinoma
Adjuvant nivo+ipilimumab fails in kidney cancer, in contrast to pembroOctober 4, 2022Renal Cell Carcinoma
Cancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
High BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
